Syndax Pharmaceuticals (SNDX) Capital Leases (2022 - 2026)
Syndax Pharmaceuticals (SNDX) reported Capital Leases of $760,000 for Q2 2026, down 42.6% from $1.33 million a year earlier and down 16.2% from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Capital Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Syndax Pharmaceuticals posted Capital Leases of $1.05 million, down 33.4% from FY2024.
- Capital Leases has a three-year compound annual growth rate of 332.4% (FY2022 to FY2025).
- By year, Capital Leases came in at $1.58 million in FY2024, $10,000 in FY2023 (-23.1%) and $13,000 in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Capital Leases since Q3 2024.
- Year over year, Capital Leases has now declined in each of the last three quarters, with an average decline of 49.6% over the last four quarters.
- The high point for year-over-year Capital Leases in five years was Q2 2023 (growth of 100.0%); the low point was Q3 2024 (a decline of 84.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $907,000 (Q1 2026), $1.05 million (Q4 2025) and $1.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Syndax Pharmaceuticals | 1.17 Bn | -558.85 Mn | 69.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 760,000.00 |
| Mar 31, 2026 | 907,000.00 |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 8,000.00 |
API Access
Syndax Pharmaceuticals Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();